Skip to main content
Log in

Small bowel tumors

  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

Abstract

Primary tumors of the small bowel are rare, and their clinical presentation is nonspecific. Consequently, preoperative diagnosis remains the exception rather than the rule. Although the small intestine makes up 75% of the length and 90% of the surface area of the gastrointestinal tract, small bowel tumors make up approximately 3% of all malignant gastrointestinal neoplasms. Primary neoplasms of the small intestine are notorious for their insidious presentation and vague symptoms, including abdominal pain, anorexia, and weight loss. These nonspecific symptoms, coupled with the lack of physical findings, often cause a significant delay in reaching a diagnosis. Because the small bowel has been a relatively inaccessible area to standard endoscopic techniques, contrast radiography has been regarded historically as the gold standard diagnostic modality. The management of primary malignant small bowel tumors is invariably surgical. However, adjuvant chemotherapy and radiotherapy may be warranted, depending on the type of tumor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Neugut AI, Jacobson JS, Suh S, et al.: The epidemiology of cancer of the small bowel. Cancer Epidemiol Biomarkers Prev 1998, 7:243–251. A wonderful review of the incidence, anatomic distribution, and various risk factors for the different types of small bowel tumors.

    PubMed  CAS  Google Scholar 

  2. Ciresi DL, Scholten DJ: The continuing clinical dilemma of primary tumors of the small intestine. Am Surg 1995, 61:698–703.

    PubMed  CAS  Google Scholar 

  3. North JH, Pack MS: Malignant tumors of the small intestine: a review of 144 cases. Am Surg 2000, 66:46–51.

    PubMed  CAS  Google Scholar 

  4. Jemal A, Thomas A, Murray T, et al.: Cancer statistics, 2002. CA Cancer J Clin 2002, 52:23–47.

    PubMed  Google Scholar 

  5. Darling RC, Welch CE: Tumors of the small intestine. Engl J Med 1959, 260:397–408.

    Article  CAS  Google Scholar 

  6. Gill S, Heuman D, Mihas A: Small intestinal neoplasms. J Clin Gastroenterol 2001, 33:267–282.

    Article  PubMed  CAS  Google Scholar 

  7. Chow JS, Chen CC, Ahsan H, et al.: A population-based study of the incidence of malignant small bowel tumors: SEER, 1973–1990. Int JEpidemiol 1996, 25:722–72.

    Article  CAS  Google Scholar 

  8. Howe JR, Karnell LH, Menck HR, et al.: The American College of Surgeons Commission on Cancer and the American Cancer Society. Adenocarcinoma of the small bowel: review of the National Cancer Data Base, 1985–1995. Cancer 1999, 86:693–706.

    Article  Google Scholar 

  9. Donohue JH: Malignant tumours of the small bowel. Surg Oncol 1994, 3:61–68.

    Article  PubMed  CAS  Google Scholar 

  10. Ashley SW, Wells SA: Tumors of the small intestine. Semin Oncol 1988, 15:116–128.

    PubMed  CAS  Google Scholar 

  11. Naef M, Buhlmann M, Baer HU: Small bowel tumors: diagnosis, therapy and prognostic factors. Langenbecks Arch Surg 1999, 384:176–10.

    Article  PubMed  CAS  Google Scholar 

  12. Minardi AJ Jr, Zibari GB, Aultman DF, et al.: Small-bowel tumors. J Am Coll Surg 1998, 186:664–668.

    Article  PubMed  Google Scholar 

  13. Arthaud JB, Guinee VF: Jejunal and ileal adenocarcinoma: epidemiological considerations. Am J Gastroenterol 1979, 72:638–46.

    PubMed  CAS  Google Scholar 

  14. Bridge MF, Perzin KH: Primary adenocarcinoma of the jejunum and ileum: a clinicopathologic study. Cancer 1975, 36:1876–1887.

    Article  PubMed  CAS  Google Scholar 

  15. Gore RM: Small bowel cancer: clinical and pathologic features. Radiol Clin North Am 1997, 35:351–360.

    PubMed  CAS  Google Scholar 

  16. Lambert P, Minghini A, Pincus W, et al.: Treatment and prognosis of primary malignant small bowel tumors. Am Surg 1996, 62:709–715.

    PubMed  CAS  Google Scholar 

  17. Garcia Marcilla JA, Sanchez Bueno F, Aguilar J, et al.: Primary small bowel malignant tumors. Eur J Surg Oncol 1994, 20:630.

    Google Scholar 

  18. O’Riordan BG, Vilor M, Herrera L: Small bowel tumors: an overview. Dig Dis Sci 1996, 14:245–257.

    CAS  Google Scholar 

  19. Caplin ME, Buscombe JR, Hilson AJ, et al.: Carcinoid tumour. Lancet 1998, 352:799–805.

    Article  PubMed  CAS  Google Scholar 

  20. Spigelman AD, William CB, Talbot IC, et al.: Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet 1989, ii:783–85.

    Article  Google Scholar 

  21. Vasen HF, Bulow S, Myrhoj T, et al.: Decision analysis in the management of duodenal adenomatosis in familial adenomatous polyposis. Gut 1997, 40:716–719.

    Article  PubMed  CAS  Google Scholar 

  22. Tomlinson IP, Houlston RS: Peutz-Jeghers syndrome. J Med Genet 1997, 34:1007–1011.

    PubMed  CAS  Google Scholar 

  23. Askling J, Linet M, Gridley G, et al.: Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology 2002, 123:1428–1435.

    Article  PubMed  Google Scholar 

  24. Catassi C, Fabiani E, Carrao G, et al.: Risk of non-Hodgkin lymphoma in celiac disease. JAMA 2002, 287:1413–1419.

    Article  PubMed  Google Scholar 

  25. Neugut AI, Marvin MR, Rella VA, et al.: An overview of adenocarcinoma of the small intestine. Oncology 1997, 11:529–536.

    PubMed  CAS  Google Scholar 

  26. Gabos S, Berkel J, Band P, et al.: Small bowel cancer in Western Canada. Int J Epidemiol 1993, 22:198–206.

    Article  PubMed  CAS  Google Scholar 

  27. Brucher BL, Roder JD, Fink U, et al.: Prognostic factors in resected primary small bowel tumors. Dig Surg 1998, 15:42–51.

    Article  PubMed  CAS  Google Scholar 

  28. Ojha A, Zacherl J, Scheuba C, et al.: Primary small bowel malignancies: single-center results of three decades. J Clin Gastroenterol 2000, 30:289–293.

    Article  PubMed  CAS  Google Scholar 

  29. Hoffman JP, Taft DA, Wheelis RF, et al.: Adenocarcinoma in regional enteritis of the small intestine. Arch Surg 1977, 112:606–612.

    PubMed  CAS  Google Scholar 

  30. Lowenfels AB: Does bile promote extra-colonic cancer? Lancet 1978, 2:239–241.

    Article  PubMed  CAS  Google Scholar 

  31. Neugut AI, Santos J: The association between cancers of the small and large bowel. Cancer Epidemiol Biomarkers Prev 1993, 2:551–553.

    PubMed  CAS  Google Scholar 

  32. Modlin IM, Sandor A: An analysis of 8305 cases of carcinoid tumors. Cancer 1997, 79:813–829. The single largest series on carcinoid tumors. This report very nicely describes the anatomic distribution of carcinoid tumors and correlates them epidemiologically with age, gender, and race as well as describing other associated malignancies and survival rates for the differing locations of carcinoid tumors.

    Article  PubMed  CAS  Google Scholar 

  33. Solcia E, Fiocca R, Rindi G, et al.: Endocrine tumors of the small and large intestine. Pathol Res Pract 1995, 191:366–372.

    PubMed  CAS  Google Scholar 

  34. Moertel CG, Sauer WG, Dockerty MB, et al.: Life history of the carcinoid tumor of the small intestine. Cancer 1961, 14:901–912.

    Article  PubMed  CAS  Google Scholar 

  35. O’Rourke MG, Lancashire RP, Vattoune JR: Carcinoid of the small intestine. Aust N Z J Surg 1986, 56:405–408.

    PubMed  CAS  Google Scholar 

  36. Weiss NS, Yang CP: Incidence of histologic types of cancer of the small intestine. J Natl Cancer Inst 1987, 78:653–656.

    PubMed  CAS  Google Scholar 

  37. Crump M, Gospodarowicz M, Shepherd FA: Lymphoma of the gastrointestinal tract. Semin Oncol 1999, 26:324–337.

    PubMed  CAS  Google Scholar 

  38. Ducreux M, Boutron MC, Piard F, et al.: A 15-year series of gastrointestinal non-Hodgkin’s lymphomas: a population-based study. Br J Cancer 1998, 77:511–514.

    PubMed  CAS  Google Scholar 

  39. Riddel RH, Petras RE, Williams GT, et al.: Tumors of the Intestines: Atlas of Tumor Pathology, series 3. Washington, DC: Armed Forces Institute of Pathology; 2002.

    Google Scholar 

  40. Mazur MT, Clark HB: Gastric stromal tumors: reappraisal of histogenesis. Am J Surg Pathol 1983, 7:507–519.

    Article  PubMed  CAS  Google Scholar 

  41. Kindblom LG, Remotti HE, Aldenborg F, et al.: Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol 1998, 152:1259–1269.

    PubMed  CAS  Google Scholar 

  42. Sircar K, Hewlett BR, Huizinga JD, et al.: Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors. Am J Surg Pathol 1999, 23:377–389.

    Article  PubMed  CAS  Google Scholar 

  43. Lasota J, Jasinski M, Sarlomo-Rikala M, et al.: Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas. Am J Pathol 1999, 154:53–60.

    PubMed  CAS  Google Scholar 

  44. Moskaluk CA, Tian Q, Marshall CR, et al.: Mutations of c-kit JM domain are found in a minority of human gastrointestinal stromal tumors. Oncogene 1999, 18:1897–1902.

    Article  PubMed  CAS  Google Scholar 

  45. Miettinen M, Lasota J: Gastrointestinal stromal tumors: definition, clinical histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 2001, 438:1–12. A well-written article clarifying the confusion of many gastroenterologists with the classification of GISTs and differentiating them clinically and pathogenetically from true leiomyomas and leiomyosarcomas.

    Article  PubMed  CAS  Google Scholar 

  46. Nagi B, Verma V, Vaiphei K, et al.: Primary small bowel tumors: a radiologic-pathologic correlation. Abdom Imaging 2001, 26:474–480.

    Article  PubMed  CAS  Google Scholar 

  47. Bender GN, Maglinte DD, Kloppel VR, et al.: CT enteroclysis: a superfluous diagnostic procedure or valuable when investigating small-bowel disease? AJR Am J Roentgenol 1999, 172:373–378.

    PubMed  CAS  Google Scholar 

  48. Buckley JA, Fishman EK: CT evaluation of small bowel neoplasms: spectrum of disease. Radiographics 1998, 18:379–392.

    PubMed  CAS  Google Scholar 

  49. Gong F, Swain P, Mills TN: Wireless endoscopy. Gastrointest Endosc 2000, 51:725–729.

    Article  PubMed  CAS  Google Scholar 

  50. Kaltsas G, Korbonits M, Heintz E, et al.: Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors. J Clin Endocrinol Metab 2001, 86:895–902.

    Article  PubMed  CAS  Google Scholar 

  51. Kvols LK, Brown ML, O’Connor MK: Evaluation of a radiolabeled somatostatin analog in the detection and localization of carcinoid and islet cell tumors. Radiology 1993, 187:129–133.

    PubMed  CAS  Google Scholar 

  52. Sarmiento JM, Thompson GB, Nagorney DM, et al.: Pancreassparing duodenectomy for duodenal polyposis. Arch Surg 2002, 137:557–563.

    Article  PubMed  Google Scholar 

  53. Branum GD, Pappas TN, Meyers WC: The management of tumors of the ampulla of Vater by local resection. Ann Surg 1996, 224:621–627.

    Article  PubMed  CAS  Google Scholar 

  54. Binmoeller KF, Boaventura S, Ramsperger K, et al.: Endoscopic snare excision of benign adenomas of the papilla of Vater. Gastrointest Endosc 1993, 39:127–131.

    PubMed  CAS  Google Scholar 

  55. Burt RW, Jacoby RF: Polyposis syndromes. In Textbook of Gastroenterology. Edited by Yamada T. Philadelphia: Lippincott Williams& Wilkins; 1999:1995–2022.

    Google Scholar 

  56. Cunningham JD, Aleali R, Aleali M, et al.: Malignant small bowel neoplasms: histopathologic determinants of recurrence and survival. Ann Surg 1997, 225:300–306.

    Article  PubMed  CAS  Google Scholar 

  57. Norton JA: Surgical management of carcinoid tumors: role of debulking and surgery for patients with advanced disease. Digestion 1994, 55:98–103.

    Article  PubMed  Google Scholar 

  58. Frilling A, Rogiers X, Malago M, et al.: Liver transplantation in patients with liver metastases of neuroendocrine tumors. Transplant Proc 1998, 30:3298–3300. This case series presents the experience of a single medical center with liver transplantation as a viable option in patients with liver metastasis from carcinoid tumors but not other neuroendocrine tumors.

    Article  PubMed  CAS  Google Scholar 

  59. Margarit C, Charco R, Hidalgo E, et al.: Liver transplantation for malignant diseases: selection and pattern of recurrence. World J Surg 2002, 26:257–263.

    Article  PubMed  Google Scholar 

  60. Akwari OE, Dozois RR, Weiland LH, et al.: Leiomyosarcoma of the small and large bowel. Cancer 1978, 42:1375–1384.

    Article  PubMed  CAS  Google Scholar 

  61. Evans H: Smooth muscle tumors of the gastrointestinal tract: a study of 56 cases followed for a minimum of 10 years. Cancer 1985, 56:2242–2250.

    Article  PubMed  CAS  Google Scholar 

  62. Pierie JP, Choudry U, Muzikansky A, et al.: The effect of surgery and grade on outcome of gastrointestinal stromal tumors. Arch Surg 2001, 136:383–389.

    Article  PubMed  CAS  Google Scholar 

  63. Crosby JA, Catton CN, Davis A, et al.: Malignant gastrointestinal stromal tumors of the small intestine: a review of 50 cases from a prospective database. Ann Surg Oncol 2001, 8:50–59.

    Article  PubMed  CAS  Google Scholar 

  64. Clary BM, DeMatteo RP, Lewis JJ, et al.: Gastrointestinal stromal tumors and leiomyosarcoma of the abdomen and retroperitoneum: a clinical comparison. Ann Surg Oncol 2001, 8:290–299.

    Article  PubMed  CAS  Google Scholar 

  65. Joensuu H, Roberts PJ, Sarlomo-Rikala M, et al.: Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 2001, 344:1052–1056. A revolutionary paper describing a patient with GIST who responded dramatically to the tyrosine kinase inhibitor ST1571.

    Article  PubMed  CAS  Google Scholar 

  66. DeMatteo RP: The GIST of targeted cancer therapy: a tumor (gastrointestinal stromal tumor), a mutated gene (c-kit), and a molecular inhibitor (STI571). Ann Surg Oncol 2002, 9:831–819. An excellent review of the mechanism of targeted therapy in patients with GISTs and the potential of targeted therapy for other malignancies that have mutated genes.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abu-Hamda, E.M., Hattab, E.M. & Lynch, P.M. Small bowel tumors. Curr Gastroenterol Rep 5, 386–393 (2003). https://doi.org/10.1007/s11894-003-0051-5

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11894-003-0051-5

Keywords

Navigation